Alzheimer's News Today

Skip to content
  • Home
  • What is Alzheimer’s Disease?
    • Stages of Alzheimer’s Disease
      • Mild: Early-Stage
      • Moderate: Middle-Stage
      • Severe: Late-stage
      • Early-Onset AD
    • Causes of Alzheimer’s Disease
    • Symptoms of Alzheimer’s Disease
      • Pseudobulbar Affect in Alzheimer’s Disease
    • Diagnosis of Alzheimer’s Disease
    • Alzheimer’s Disease Statistics
    • Living with Alzheimer’s Disease
  • Alzheimer’s Disease Treatment
    • Approved Treatments for Alzheimer’s Disease
      • Aricept (Donepezil)
      • Exelon (Rivastigmine)
      • Namenda (Memantine)
      • Namzaric (Donepezil and Memantine)
      • Nuedexta
      • Oligomannate
      • Razadyne (Galantamine)
    • Experimental Treatments for Alzheimer’s Disease
      • Anti-Agitation Medication
        • AVP-786
        • AXS-05
        • Brexpiprazole
        • Prazosin
      • Neurotransmitter Modifying Medication
        • DB105 (ORM-12741)
        • Nuplazid (Pimavanserin)
        • PXT864
        • Riluzole
        • SUVN-502
      • Non-Drug Treatments
        • Deep Brain Stimulation of the Fornix
        • Repetitive Transcranial Magnetic Stimulation (rTMS)
      • Treatments That Target Amyloid-Beta
        • ABvac40
        • Aducanumab
        • Allopregnanolone
        • ALZT-OP1
        • BAN2401
        • CAD106
        • Crenezumab
        • Donanemab (LY3002813)
        • Elayta (CT1812)
        • Gantenerumab
        • Lu AF20513
        • PMN310
        • PMN330
        • PMN350
        • PQ912
        • Saracatinib
        • Solanezumab
        • UB-311
      • Treatments That Target Tau
        • AADvac1
        • ABBV-8E12
        • ACI-35
        • LMTX
        • RO7105705
        • Zagotenemab (Formerly LY3303560)
      • Treatments with Other Modes of Action
        • Anavex 2-73
        • Azeliragon
        • Carvedilol
        • Curcumin
        • Leukine (Sargramostim)
        • Liraglutide
        • Nicotinamide
        • Nasal Insulin
        • Piromelatine
        • Sumifilam (PTI-125)
        • Resveratrol
        • S-equol
        • T3D-959
        • Thiethylperazine
        • Telmisartan
        • TPI 287
        • Xanamem
      • Treatments No Longer Under Development
        • Atabecestat (Formerly JNJ-54861911)
        • CNP520 (Umibecestat)
        • Elenbecestat
        • Gemfibrozil
        • Intepirdine
        • Lanabecestat
        • Lumateperone (ITI-007)
        • LY3202626
        • Thalidomide
  • Columns
    • Dementia Days
    • Treading Dark Waters
  • Login
  • Subscribe
  • COVID-19 Info
    • COVID-19 Updates

Resources

Home » Resources

  • pha
    PH Association
  • nih
    National Institute of Health
  • wiki
    Wikipedia – Pulmonary Hypertension
  • canada
    PH Canada
  • Screen Shot 2014-05-19 at 4.47.55 AM
    American Heart Association
  • drugs
    Drugs.com
  • phcentral
    PH Central
  • knowph
    Know Your PH
  • trials
    Clinical Trials

Create your own user feedback survey

Recent Posts

  • donanemab

    Donanemab Found to Slow Cognitive, Functional Decline in Early Alzheimer’s

    January 13, 2021

  • BXCL501, top-line results

    BXCL501 Led to Fast, Safe, Durable Drop in Agitation in Dementia Patients

    January 11, 2021

  • Support for Alzheimer’s research, care

    Support for Research, Patient Care in US 2021 Budget Wins Praise

    January 6, 2021

Featured Posts

Caregiving Is a Judgment-free Zone

July 6, 2020

risk factors, exercise, control, judgment, father's day, awareness month, empathy, togetherness, fear

Simple Solutions to Everyday Caregiving Challenges

June 29, 2020

risk factors, exercise, control, judgment, father's day, awareness month, empathy, togetherness, fear

Father’s Day Prompts Memories of My Mom’s Dementia Diagnosis

June 22, 2020

risk factors, exercise, control, judgment, father's day, awareness month, empathy, togetherness, fear
Visit Alzheimer's News Today's profile on Pinterest.

Alzheimer’s News Today

BioNews Services, LLC
3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363
  • Subscription Support
  • Publishing Team
  • Leadership
  • Our Values
  • Corrections Policy
  • Contact Us
  • Privacy Policy
  • Terms of Service

Disclaimer:

Alzheimer's News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright © 2013-2021 All rights reserved.
We use cookies to enhance your experience on our website. Privacy Policy Accept